All Releases
 |
Athersys Added to Russell Microcap Index
Jul 2, 2008
|
12.6 KB |
|
| |
CLEVELAND, Jul 2, 2008 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it was added to the Russell Microcap(r) Index when Russell Investments reconstituted its comprehensive family of U.S. indexes on June 27, 2008.
According to the Russell Investment Group, the Russell indexes are widely used by investmen...
|
|
Athersys to Present At Canaccord Adams Diabetes and Obesity Conference
Jun 2, 2008
|
8.9 KB |
|
| |
CLEVELAND, Jun 2, 2008 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will present at the Canaccord Adams annual Diabetes and Obesity Conference, to be held Friday, June 6, 2008 at the Hotel Nikko San Francisco in San Francisco, California.
Gil Van Bokkelen, Chairman and Chief Executive, and William (...
|
|
Athersys Reports 2008 First Quarter Results
May 8, 2008
|
16.3 KB |
|
| |
CLEVELAND, May 8, 2008 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the quarter ended March 31, 2008.
First Quarter Highlights Include:
* Revenues of $0.8 million and a net loss of $4.7 million were
recorded for the quarter ended March 31, 2008;
* A Phase I cl...
|
|
Athersys to Host First Quarter 2008 Financial Results Call
Apr 15, 2008
|
9.3 KB |
|
| |
CLEVELAND, Apr 15, 2008 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its first quarter 2008 financial results at approximately 4:00 PM (Eastern Time) on Thursday, May 8, 2008, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkelen, Ch...
|
|
Athersys Reports Fourth Quarter and 2007 Annual Results
Mar 13, 2008
|
21.3 KB |
|
| |
CLEVELAND, Mar 13, 2008 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the fourth quarter of 2007 and for the year-ended December 31, 2007.
Fourth Quarter and Recent Highlights Include:
* Revenues of $0.8 million and a net loss of $4.7 million for the
fourth quart...
|
|
Athersys to Present At Cowen's 28th Annual Health Care Conference
Mar 10, 2008
|
9.0 KB |
|
| |
CLEVELAND, Mar 10, 2008 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will present at the Cowen and Company 28th Annual Health Care Conference, to be held March 17-20, 2008, at The Boston Marriott Copley Place in Boston.
Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehma...
|
|
Athersys to Present At Susquehanna Second Annual Healthcare Options Conference
Feb 29, 2008
|
9.0 KB |
|
| |
CLEVELAND, Feb 29, 2008 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will present at the Second Annual SIGnificant Investment Options in Healthcare Conference, hosted by Susquehanna Financial Group, to be held March 4-5, 2008, at The W Hotel in New York City.
Gil Van Bokkelen, Chairman and Chief Exe...
|
|
Athersys Announces Summary Results for Phase 1 Safety Study of Its Novel Obesity Drug
Feb 27, 2008
|
14.1 KB |
|
| |
Feb 27, 2008 (PrimeNewswire via COMTEX News Network) --
Conference Call Today At 4:15 PM (Eastern Time)
CLEVELAND, Feb. 27, 2008 (PRIME NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced top-line results from its Phase 1 clinical trial of ATHX-105, its orally administered drug candidate for the treatment of obesity. ...
|
|
Athersys to Host Obesity Drug Phase I Data Results Conference Call
Feb 26, 2008
|
9.4 KB |
|
| |
CLEVELAND, Feb 26, 2008 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will host a conference call on Wednesday, February 27, 2008 at 4:15 PM (Eastern Time) to review the top-line data results of the Phase I clinical trial of ATHX-105, its leading drug development candidate for the treatment of obesity.
...
|
|
Athersys to Host Fourth Quarter 2007 Results Call
Feb 15, 2008
|
9.3 KB |
|
| |
CLEVELAND, Feb 15, 2008 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its fourth quarter 2007 financial results at approximately 4:00 PM (Eastern Time) on Thursday, March 13, 2008, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkelen...
|
|
Athersys Receives IND Authorization for MultiStem in Acute Myocardial Infarction
Dec 20, 2007
|
12.6 KB |
|
| |
CLEVELAND, Dec 20, 2007 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has received authorization from the U.S. Food and Drug Administration (FDA) to begin a Phase I clinical trial evaluating the safety of MultiStem(r) administration in the treatment of acute myocardial infarction (AMI).
This aut...
|
|
Athersys Commences Trading On NASDAQ Capital Market
Dec 12, 2007
|
11.7 KB |
|
| |
CLEVELAND, Ohio, Dec 12, 2007 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) announced that effective today its common stock will commence trading on the NASDAQ Capital Market. The stock previously traded on the OTC Bulletin Board under the symbol "AHYS".
"Today's announcement, combined with the continued progress in ou...
|
|
Athersys IND for MultiStem Authorized for Phase I Clinical Trial in Bone Marrow Transplant Support
Nov 15, 2007
|
12.4 KB |
|
| |
CLEVELAND, Nov 15, 2007 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (OTCBB:AHYS) announced today that it has been notified by the U.S. Food and Drug Administration (FDA) that its Investigational New Drug, MultiStem(r), can proceed to a Phase I clinical trial evaluating the safety of MultiStem administration in support of bone marrow t...
|
|
Athersys Reports Third Quarter 2007 Financial Results
Nov 14, 2007
|
12.1 KB |
|
| |
CLEVELAND, Nov 14, 2007 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (OTCBB:AHYS) today announced its financial results for the third quarter of 2007.
For the third quarter of 2007, the company reported revenues of $860,000 and a net loss of $4.4 million, principally associated with costs incurred in research and development and ge...
|
|
Athersys to Present At Lazard Capital Markets Fourth Annual Healthcare Conference
Oct 31, 2007
|
8.6 KB |
|
| |
CLEVELAND, Oct 31, 2007 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (OTCBB:AHYS) today announced it will present at the Lazard Capital Markets Fourth Annual Healthcare Conference to be held November 27-28, 2007, at The New York Palace in New York City.
Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehm...
|
|
Athersys to Host Third Quarter Results Call
Oct 29, 2007
|
9.0 KB |
|
| |
CLEVELAND, Ohio, Oct 29, 2007 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (OTCBB:AHYS) today announced it will release its third quarter 2007 financial results at approximately 6:00 AM (Eastern Time) on Wednesday, November 14, 2007, and host a conference call at 8:30 AM (Eastern Time) to review the results. Gil Van Bokkelen, Chairman ...
|
|
Athersys' Registration Statement On Form S-3 Declared Effective by the SEC
Oct 18, 2007
|
8.5 KB |
|
| |
CLEVELAND, Oct 18, 2007 (PrimeNewswire via COMTEX News Network) -- Athersys, Inc. (OTCBB:AHYS), announced that its Registration Statement on Form S-3 was declared effective on Thursday, October 18, 2007, by the Securities and Exchange Commission. The Registration Statement registers for resale 13,531,781 shares of the company's common stock on beha...
|
|
Athersys Elects Jeff Randall To Board Of Directors
Sep 5, 2007
|
10.2 KB |
|
| |
Cleveland, OH, September 05, 2007 - Athersys, Inc. (OTC BB: AHYS) today announced that Lorin Jeffry Randall was elected to the Board of Directors and appointed as Chairman of the Audit Committee. Mr. Randall has an extensive background in the healthcare and technology industries, with over 20 years of experience as a senior ex...
|
|
Athersys Announces Completion Of Name Change And New Ticker Symbol, AHYS
Sep 5, 2007
|
9.5 KB |
|
| |
Cleveland, OH, September 05, 2007 - Athersys, Inc. (OTCBB: AHYS), today announced that it has completed its planned name change from BTHC VI, Inc. (OTCBB: BVIC). Effective September 6, 2007, the company's new ticker symbol on the Over the Counter Bulletin Board is AHYS. The new CUSIP number is 04744L106 following the name chan...
|
|
Athersys Reports Second Quarter 2007 Financial Results
Aug 17, 2007
|
11.5 KB |
|
| |
Cleveland, OH, August 17, 2007 - Athersys, Inc. (OTC Bulletin Board: BVIC), a wholly owned subsidiary of BTHC VI, today announced its financial results for the second quarter of 2007. This announcement marks Athersys' first financial report since it became a publicly traded company after its merger with BTHC VI, Inc., which wa...
|
|
|
= add release to Briefcase |
|
 |
|
Jul 3, 2008
1:00 PM ET
$2.80  0.50
Quotes delayed at least 20 minutes.
Information provided by TurboFeed.
|
|
 |
|
